Please ensure Javascript is enabled for purposes of website accessibility

Novavax(NVAX)

Nasdaq Global Select

NVAX
Novavax Stock Quote
$41.47 $1.13 2.8%
Price as of August 12, 2022, 4:00 p.m. ET View Interactive NVAX Charts

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Interactive Chart


Compare NVAX Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
NVAX
Novavax
$41.47 $3B -83.9% 101.3%
NVTA
$5.37 $1B -79.4% -45.8%
EDIT
$18.77 $1B -70.0% -19.0%
BHC
$6.01 $2B -78.2% -56.4%
CRLBF
$3.48 $1B -66.6%

News & Analysis: Novavax

The Fool has written over 900 articles on Novavax.

All

Market Moves

Podcasts

Earnings











Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.